Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1448312

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1448312

Global Gene Amplification Technologies Market Size, Share, Growth Analysis, By Technology(PCR, NASBA), By End user(Academic & research institutions, diagnostic labs) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Gene Amplification Technologies Market size was valued at USD 3.96 billion in 2022 and is poised to grow from USD 4.36 billion in 2023 to USD 9.34 billion by 2031, growing at a CAGR of 10% during the forecast period (2024-2031).

The development of molecular biology and diagnostics has led to a strong increase in the global market for gene amplification technologies. Personalized medicine, biotechnology research, and growing applications in disease diagnostics are important motivators. The industry is dominated by isothermal and polymerase chain reaction (PCR) amplification methods, however CRISPR-based amplification is becoming more and more popular. Due to its robust R&D and healthcare infrastructure, North America has a sizable market share. Asia-Pacific is growing quickly as a result of increased healthcare spending and technology usage. With genomics continuing to influence the medical and research fields, the market for gene amplification technologies is expected to grow steadily.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Amplification Technologies Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Amplification Technologies Market Segmental Analysis

One may divide the worldwide market for gene amplification technologies into three segments: technology, end-user, and geography. Some examples of technological segments are LAMP, NASBA, PCR, and others. Pharmaceutical firms, academic and research institutes, and diagnostic labs are examples of end-users. The market is split geographically into Latin America, North America, Europe, Asia Pacific, the Middle East, and Africa.

Drivers of the Global Gene Amplification Technologies Market

The global market for gene amplification technologies is expanding due to the growing need for customized treatment and biotechnology breakthroughs. These technologies allow for the accurate and efficient examination of genetic material for research and diagnostic reasons.

Restraints in the Global Gene Amplification Technologies Market

Market expansion is impeded by ethical concerns over genetic manipulation, intricate regulatory frameworks, and high costs linked to gene amplification technologies. These factors may limit the broad use and growth of these technologies in the worldwide market.

Market Trends of the Global Gene Amplification Technologies Market

Key developments in the global gene amplification technologies market include the quick development of CRISPR-Cas9 technology, which allows for accurate and effective gene editing. Market growth is being propelled by expanding applications in biotechnology, agriculture, and medical research. Furthermore, the need for gene amplification techniques is fueled by the growth of customized medicine and synthetic biology. Efficiency gains come from automation and high-throughput capacities. Nonetheless, there are still issues with genetic modification in terms of ethics and regulations. All things considered, the market is driven by innovation, a wide range of applications, and rising funding for genetic research, with an emphasis on both therapeutic and non-therapeutic uses.

Product Code: SQMIG35H2150

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Gene Amplification Technologies Market by Technology

  • Market Overview
  • PCR
  • NASBA
  • LAMP
  • and others

Global Gene Amplification Technologies Market by End user

  • Market Overview
  • Academic & research institutions
  • diagnostic labs
  • and pharmaceutical companies

Global Gene Amplification Technologies Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Thermo Fisher Scientific (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beckman Coulter (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fluidigm Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMerieux (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenMark Diagnostics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Luminex Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzo Biochem (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaSorin S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eppendorf (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!